170 related articles for article (PubMed ID: 29485436)
1. Metastasis to the Sellar/Suprasellar Region in a Patient With Endometrial Carcinoma Detected by 18F-FDG PET/CT.
Salvatore B; D'Amico D; Fonti R
Clin Nucl Med; 2018 May; 43(5):363-364. PubMed ID: 29485436
[TBL] [Abstract][Full Text] [Related]
2. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
3. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
4. The Value of Preoperative Positron Emission Tomography/Computed Tomography in Node-Negative Endometrial Cancer on Magnetic Resonance Imaging.
Park JY; Lee JJ; Choi HJ; Song IH; Sung CO; Kim HO; Chae SY; Kim YT; Nam JH
Ann Surg Oncol; 2017 Aug; 24(8):2303-2310. PubMed ID: 28550488
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT diagnostic criteria may need adjustment based on MRI to estimate the presurgical risk of extrapelvic infiltration in patients with uterine endometrial cancer.
Sudo S; Hattori N; Manabe O; Kato F; Mimura R; Magota K; Sugimori H; Hirata K; Sakuragi N; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):676-84. PubMed ID: 25504022
[TBL] [Abstract][Full Text] [Related]
7. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
[TBL] [Abstract][Full Text] [Related]
8. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT.
Yin H; Hu Y; Xiu Y; Luo R; Shi H
Clin Nucl Med; 2019 Jul; 44(7):e425-e427. PubMed ID: 30985410
[TBL] [Abstract][Full Text] [Related]
9. 18F-FDG PET in the management of endometrial cancer.
Chao A; Chang TC; Ng KK; Hsueh S; Huang HJ; Chou HH; Tsai CS; Yen TC; Wu TI; Lai CH
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):36-44. PubMed ID: 16167154
[TBL] [Abstract][Full Text] [Related]
10. Pituitary Metastasis of Non-Small Cell Lung Cancer With High FDG Uptake on PET/CT Pituitary Metastasis of Non-Small Cell Lung Carcinoma.
Le Meur C; Campedel L; Kharroubi D; Amrane K
Clin Nucl Med; 2022 Jul; 47(7):e506-e508. PubMed ID: 35426872
[TBL] [Abstract][Full Text] [Related]
11. A rare case of non-small cell lung cancer metastasizing to the pituitary gland: detection with (18)F-FDG PET-CT.
Agarwal KK; Sharma P; Singla S; Suman Kc S; Bal C; Kumar R
Clin Nucl Med; 2014 May; 39(5):e318-9. PubMed ID: 23603606
[TBL] [Abstract][Full Text] [Related]
12. Comparison of FDG PET/CT and MRI in lymph node staging of endometrial cancer.
Kim HJ; Cho A; Yun M; Kim YT; Kang WJ
Ann Nucl Med; 2016 Feb; 30(2):104-13. PubMed ID: 26546334
[TBL] [Abstract][Full Text] [Related]
13. Solitary Splenic Metastasis From Endometrial Carcinoma Revealed on FDG PET/CT.
Xiao L; Li Y; Li L
Clin Nucl Med; 2022 Dec; 47(12):e744-e745. PubMed ID: 35605058
[TBL] [Abstract][Full Text] [Related]
14. Increased 18F-2-Fluorodeoxysorbitol (18F-FDS) Activity in a Pituitary Spindle Cell Carcinoma.
Cheng X; Zhu W; Cui R
Clin Nucl Med; 2016 Dec; 41(12):953-955. PubMed ID: 27764039
[TBL] [Abstract][Full Text] [Related]
15. 18F-FDG PET/CT findings in endometrial cancer patients: the correlation between SUVmax and clinicopathologic features.
Boonya-ussadorn T; Choi WH; Hyun J; Kim SH; Chung SK; Yoo IeR
J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S115-22. PubMed ID: 25518184
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT Versus Contrast-Enhanced CT for Staging and Prognostic Prediction in Patients With Salivary Gland Carcinomas.
Park MJ; Oh JS; Roh JL; Kim JS; Lee JH; Nam SY; Kim SY
Clin Nucl Med; 2017 Mar; 42(3):e149-e156. PubMed ID: 28072618
[TBL] [Abstract][Full Text] [Related]
17. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
18. Adrenal and Bone Metastases as the Initial Presentation of Endometrial Carcinoma Diagnosed by 18F-FDG PET/CT.
Su M; Sun J; Fan Q; Tian R
Clin Nucl Med; 2020 Sep; 45(9):711-713. PubMed ID: 32520505
[TBL] [Abstract][Full Text] [Related]
19. All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies.
Miljić D; Manojlović-Gačić E; Skender-Gazibara M; Milojević T; Bogosavljević V; Kozarević N; Petrović N; Stojanović M; Pekić S; Doknić M; Petakov M; Popović V
Endokrynol Pol; 2017; 68(3):352-359. PubMed ID: 28660992
[TBL] [Abstract][Full Text] [Related]
20. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
